tiprankstipranks

William Lewis Insider Profile

11 Followers
William Lewis, Chair and CEO, Director at Insmed, holds 648.04K shares in Insmed (Ticker: INSM), holds ― shares in uniQure (Ticker: QURE), holds ― shares in NewAmsterdam Pharma Company (Ticker: NAMS). Most recently, William Lewis Bought ― shares of Insmed on Feb 29, 2024 for an estimated value of 629.00K.
tipranks
William Lewis

William Lewis
Insmed (INSM)
Chair and CEO, Director

Ranked #20,276 out of 98,624 Corporate Insiders

Profitable Transactions

62%
8 out of 13 Profitable Transactions

Average Return

+5.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$16M
100.00%
0.00%
0.00%
A breakdown of William Lewis's holdings

Insider Roles

Insmed
(INSM)
Chair and CEO, Director
uniQure
(QURE)
Director
NewAmsterdam Pharma Company
(NAMS)
Director
Roles that William Lewis holds in companies

Most Profitable Insider Trade

Stock:
Insmed
(INSM)
Rating:Informative Buy
Date:Nov 02, 2018 - Nov 02, 2019
Return:+56.70%
The most profitable trade made by William Lewis

William Lewis's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Insmed
Feb 29, 2024
Chair and CEO, Director
Informative Buy
629.00K
$16.07M
uniQure
Director
NewAmsterdam Pharma Company
Director
AEGR
Aegerion
Oct 27, 2010
Informative Buy
266.05K
$813.14K
List of latest transactions for each holding click on a transaction to see William Lewis's performance on stock

William Lewis insider profile FAQ

What is the percentage of profitable transactions made by William Lewis?
The percentage of profitable transactions made by William Lewis is 62%.
    What is the average return per transaction made by William Lewis?
    The average return per transaction made by William Lewis is 5.40%.
      What stocks does William Lewis hold?
      William Lewis holds: INSM, QURE, NAMS, AEGR stocks.
        What was William Lewis’s latest transaction?
        William Lewis latest transaction was an Informative Buy of $629.00K.
          What was William Lewis's most profitable transaction?
          William Lewis’s most profitable transaction was an Informative Buy of INSM stock on November 2, 2018. The return on the trade was 56.70%.
            What is William Lewis's role in Insmed?
            William Lewis's role in Insmed is Chair and CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.